The digital PCR (dPCR) market share is expected to witness significant growth in the coming years. Digital PCR is a powerful technique that enables the precise quantification and detection of nucleic acids, making it an essential tool in various fields such as research, diagnostics, and forensics.

One of the key factors driving the market share of dPCR is its superior accuracy and sensitivity compared to traditional PCR methods. Digital PCR allows for absolute quantification of target DNA or RNA molecules by partitioning them into thousands of individual reactions. This partitioning eliminates the need for standard curves or reference samples, resulting in more accurate and reliable results.

Moreover, dPCR offers several advantages over other molecular diagnostic techniques, such as real-time PCR. It provides higher precision and reproducibility, enabling researchers to detect rare genetic mutations or low-abundance targets with greater confidence. This makes dPCR particularly valuable in applications like liquid biopsy for cancer detection, prenatal testing, infectious disease monitoring, and genetic profiling.

Another factor contributing to the popularity of dPCR is its ability to analyze multiple targets simultaneously, allowing for efficient and comprehensive genetic analysis in various research fields.

The Digital PCR-dPCR Market size was valued at US$ 419.25 Million in 2022 and is projected to reach US$ 2196.40 Million by 2030, with a growing CAGR of 23% during the forecast period 2023-2030.

Get Free Sample Report @ https://www.snsinsider.com/sample-request/1038

KEY MARKET SEGMENTATION:

By Technology

• Droplet Digital PCR
• Chip Based Digital PCR
• Beaming Digital PCR

By  Product Type

• Digital PCR Systems
• Consumables And Reagents
• Software And Services

By Application

• Clinical Diagnostics
• Forensic And Others
• Research

By End-Use

• Pharmaceuticals And Biotechnology Industries
• Clinical Diagnostic Laboratories
• Universities And Other Organizations

Some of the major key players are as follows: Thermo Fisher Scientific, Bio-Rad Laboratories Inc., Hoffmann-La Roche, Ltd., Abbott Laboratories, Agilent Technologies, Analytik Jena AG, Becton Dikinson and Company, bioMérieux SA, Danaher Corporation, Eppendorf, Fluidigm Corporation, Merck KGaA, QIAGEN N.V., Takara Bio, Meridian Bioscience, Promega Corporation, Enzo Life Sciences, Inc., Bioneer, ELITech Group, Quidel Corporation, and Others.

About US:

SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.

We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.

Contact Us:

Akash Anand – Head of Business Development & Strategy,

info@snsinsider.com,

Phone: +1-415-230-0044 (US) | +91-7798602273 (IND),

Website: https://www.snsinsider.com